Foghorn Therapeutics Inc. (FHTX) NASDAQ
3.63
-0.345(-8.68%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.63
-0.345(-8.68%)
Currency In USD
| Market Cap | 340.1M |
| Enterprise Value | 300.49M |
| P/E Ratio | -3.35 |
| PEG Ratio | -0.23 |
| Price/Sales Ratio | 7.55 |
| Price/Book Ratio | -3.3 |
| Enterprise/Revenue | 5.89 |
| Enterprise/EBITDA | -2.3 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -2.67 |
| Operating Margin | -2.86 |
| Return On Assets | -0.34 |
| Return On Equity | 0.86 |
| Revenue | 30.91M |
| Revenue/Share | 0.41 |
| Gross Profit | 27.58M |
| EBITDA | -78.78M |
| Net Income | -74.28M |
| Diluted EPS | -1.18 |
| Total Cash | 184.88M |
| Total Cash/Share | 2.66 |
| Total Debt | 41.99M |
| Total Debt/Equity | -0.55 |
| Current Ratio | 2.92 |
| Book Value Per Share | -1.1 |
| 52-Week Change | -16.74 |
| 52-Week High | 6.95 |
| 52-Week Low | 3.27 |
| Moving Average 50 Days | 4.62 |
| Moving Average 200 Days | 4.94 |
| Average Volume | 160,382 |
| Shares Outstanding | 58.71M |
| % Held by Institutions | 70.56 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |